Use of eltrombopag after romiplostim in primary immune thrombocytopenia

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|1|111-116

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.1, 2015-04, pp. : 111-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : E40-E43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 6, 2015-06 ,pp. : 682-683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Usage of Eltrombopag for Chronic Immune Thrombocytopenia as a Pretreatment for Splenectomy

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-10 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?

By  

Acta Haematologica, Vol. 133, Iss. 1, 2014-08 ,pp. : 78-82

Karger

Access to resources Recommend Favorite

Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity

By  

Acta Haematologica, Vol. 134, Iss. 4, 2015-0 ,pp. : 215-228

Karger

Access to resources Recommend Favorite